Increased Focal Adhesion Kinase- and Urokinase-type Plasminogen Activator Receptor-associated Cell Signaling in Endothelial Cells Exposed to Asbestos A. Barchowsky, B.M. Lannon, L.C. Elmore, and M.D. Treadwell Department of Pharmacology, Dartmouth Medical School, Hanover, New Hampshire Exposure of low-passage endothelial cells in culture to nonlethal amounts of asbestos, but not refractory ceramic fiber-1, increases cell motility and gene expression. These changes may be initiated by the fibers mimicking matrix proteins as ligands for receptors on the cell surface. In the present study, 1- to 3-hr exposures of endothelial cells to 5 mg/cm2 of chrysotile asbestos caused marked cell elongation and motility. However, little morphological change was seen when chrysotile was added to cells pretreated with either mannosamine to prevent assembly of glycophosphatidylinositol (GPI)-anchored receptors or with herbimycin A to inhibit tyrosine kinase activity. Affinity purification of GPI-anchored urokinase-type plasminogen activator receptor (uPAR) from chrysotile-exposed cells demonstrated that asbestos altered the profile of proteins and phosphoproteins complexed with this receptor. Tyrosine kinase activities in the complexes were also increased by asbestos. Immunoprecipitations with selective monoclonal antibodies demonstrated that both chrysotile and crocidolite asbestos increase kinase activities associated with p60 Src or p120 focal adhesion kinase (FAK). Further, chrysotile also changed the profile of proteins and phosphoproteins associated with FAK in intact cells. These data suggest that asbestos initiates endothelial cell phenotypic change through interactions with uPAR-containing complexes and that this change is mediated through tyrosine kinase cascades.- Environ Health Perspect 105(Suppl 5):1131-1137 (1997) Key words: focal adhesion kinase, endothelial, urokinase-type plasminogen activator receptor, asbestos, Src kinase Introduction Inhalation of asbestos fibers is a major health risk causing pulmonary fibrosis (asbestosis), mesotheliomas, and lung carcinomas (1-3). Hallmarks of asbestosis include increased fibrinolysis (4), expansion of interstitial matrix components (5), and angiogenesis (6). These events are indica- tive of activated pulmonary cells, which require enhanced pericellular proteolytic activity and matrix interactions for cell motility and proliferation (7-9). Many studies have examined the pathogenesis of pneumoconiosis related to asbestos or other fibers, yet few have investigated cellular and molecular mechanisms for activation of vas- cular cells contacted by fibers (3,5). Inhaled chrysotile asbestos fibers accumulate along capillaries and penetrate into the capillary lumen (3,10). Asbestos increases the permeability of the pulmonary endothelium, the proliferative rates of endothelial cells (6,10), and the synthesis This paper is based on a presentation at The Sixth International Meeting on the Toxicology of Natural and Man- Made Fibrous and Non-Fibrous Particles held 15-18 September 1996 in Lake Placid, New York. Manuscript received at EHP26 March 1997; accepted 31 March 1997. This work was supported by the following grants from the National Institutes of Health: HL52738 (AB), ES07373 (AB), and OH03267 (MDT). Address correspondence to Dr. A. Barchowsky, Department of Pharmacology, Dartmouth Medical School, 7650 Remsen, Hanover, NH 03755. Telephone: (603) 650-1673. Fax: (603) 650-1129. E-mail: barchowsky@dart- mouth.edu Abbreviations used: BSA, bovine serum albumin; DMEM, Dulbecco's modified Eagle's medium; FAK, focal adhesion kinase; FBS, fetal bovine serum; GPI, glycophosphatidylinositol; PAGE, polyacrylamide gel elec- trophoresis; PBS, phosphate-buffered saline; RCF, refractory ceramic fiber; uPA, urokinase-type plasminogen activator; uPAR, uPA receptor. of proteins associated with wound repair or fibrosis (11-13). Several weeks after a sin- gle 1-hr exposure to chrysotile asbestos, aberrant pulmonary endothelial and smooth muscle cell proliferation occurs in the small arterioles and venules of animals (10). Recent studies using cultured cells demon- strated that noncytotoxic concentrations of asbestos, but not refractory ceramic fiber-1 (RCF-1), induce an activated endothelial cell phenotype (14). This phenotype is elongated, has increased motility, and increased expression of adhesion molecules for phagocytes (14). Vascular remodeling and activated endothelial cells are associated with increased proteolytic cascades, which are initiated by activation of urokinase-type plasminogen activator (uPA). uPA activity is elevated in many physiological settings requiring vas- cular cell motility and proliferation, such as ovulation, angiogenesis, tumor metastasis, and smooth muscle or monocyte migration in atherosclerosis (8). Expression of uPA receptor (uPAR) is also increased in remod- eling and can be induced by cytokines, hor- mones, and tumor promoters (8,9). The binding of uPA to uPAR is central to the role of endothelial cells in tissue remodel- ing and is essential for endothelial cell motility (8,15-17). The effects of uPA on cell morphology, motility, and prolifera- tion require receptor occupancy, but often not uPA proteolytic activity (18-20). uPAR is a glycophosphatidylinositol (GPI)-anchored surface receptor that local- izes either to insoluble lipid-protein com- plexes(21,22) on the cell surface or to focal adhesions attached to matrix-bound vitronectin (23,24). Addition of the gly- coinositol phospholipid to the carboxyl tail of uPAR allows targeting and insertion into the outer cell membrane. GPI-anchored receptors have no transmembrane domain but transduce signals through soluble kinases associated with the inner mem- brane leaflet through N-terminal lipid modifications(22,25-28). Both tyrosine (22,27) and serine/threonine kinases (28) complex with GPI-anchored receptors to mediate their responses. Further, uPAR com- plexes with integrin-containing signaling complexes (22) and can regulate integrin function (29). Endothelial cells responding to asbestos elongate and move around the fibers (14). Direct activation of endothelial cells by asbestos could be explained by the fibers mimicking ligands, such as fibronectin or Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 .......... . ------------ 1 131 BARCHOWSKY ET AL. vitronectin, which bind cell surface proteins (30,31). Boylan et al. (31) demonstrated that pleural mesothelial cells internalize vitronectin or serum-coated cro- cidolite asbestos fibers via an avb5 integrin- dependent mechanism. However, the affinity of vitronectin for uPAR is higher than its affinity for integrins (24). As dis- cussed above, activation of uPAR promotes endothelial cell motility and deformability (17). Therefore, the role of uPAR in initi- ating cell signaling linked to morphological and phenotypical change was examined in second- to fourth-passage porcine aortic or human microvascular endothelial cells. The data obtained demonstrate that asbestos requires both GPI-anchored receptors and tyrosine phosphorylation to elicit morpho- logical change. Chrysotile asbestos alters the profiles of proteins complexed with uPAR and activates tyrosine kinases in these complexes. Chrysotile and crocidolite asbestos, but not RCF-1, activate endothe- lial cell tyrosine kinases. These studies sug- gest that activation of uPAR-signaling complexes and tyrosine-kinase cascades provides an axis for induction of gene expression and phenotypic change in response to asbestos. Materials and Methods Materials. Culture media, balanced salts solutions, culture supplements, GRGDSP peptide, and trypsin were from Life Technologies (Gaithersburg, MD). Characterized fetal bovine serum (FBS) was from Hyclone Laboratories (Logan, UT). [35S] methionine (Expre35S35, 1000 Ci/mmol) and [32P] orthophosphate (9000 Ci/mmol) were from Dupont/New England Nuclear (Boston, MA). Growth factors, protease inhibitors, and mannosamine were from Sigma (St. Louis, MO). All other reagents were of the highest purity available. Cell Culture. Porcine endothelial cells were enzymatically isolated from fresh aortas as previously described (32). Third passage human pulmonary microvascular endothelial cells were obtained from Clonetics Corporation (San Diego, CA). Both cell types were cultured to confluence in 0.1% gelatin-coated 25 cm2 flasks con- taining the defined endothelial cell medium (33): MCDB 131 media containing 10 ng/ml human epidermal growth factor, 1.0 pg/mi hydrocortisone, and 5% FBS. The cultures were maintained at 37?C under an atmosphere of 5% CO2/ 95% air and post- confluent monolayers were used in all experiments. Greater than 95% of the cells tested positive for endothelial cell-specific markers such as antigenicity for antifactor VIII antibody and for rapid uptake of Di-I acetylated LDL (32). The culture medium was replaced 18 hr prior to the beginning of an experiment and fiber additions were made in the presence or absence of serum as indicated. Fiber Samples. Reference samples of National Institute of Environmental Health Sciences chrysotile and crocidolite asbestos used in these studies were obtained from B. Mossman (University of Vermont, Burlington, VT). All fibers were greater than 10 p. Working preparations of fibers were baked at 200?C for 12 hr to remove endotoxin or other biological contami- nants. The fibers were then diluted in ster- ile Dulbecco's modified Eagle's medium (DMEM) and tested for endotoxin using the E-toxate assay (Sigma). Metabolic Labeling of Intact Cells. Confluent cells were metabolically labeled with [32P] orthophosphate as previously described (34,35). Briefly, cells were rinsed in low phosphate MEM and then incu- bated in the same buffer with 0.1 mCi/ml of carrier-free [32P] orthophosphate for 1 hr at 37?C, under 5% C02/95% air. Asbestos was then added for up to 1 hr, and expo- sures were stopped by rinsing the cells twice with cold stop buffer (10 mM Tris-HCl, pH 7.4, 10 mM EDTA, 5 mM EGTA, 100 mM NaF, 200 mM sucrose, 100 pM Na-orthovanadate, 5 mM pyrophosphate, 4 pg/ml leupeptin, 4 pg/ml soybean trypsin inhibitor, 1 mM benzamidine, 20 pM calpain inhibitor 1, 100 mU/ml aprotinin, and 100 pM phenylmethylsulfonyl fluo- ride). The cells were then lysed at room temperature in 10 mM Tris-HCI, pH 8.0, 2 mM EDTA, 0.2 M sucrose, 0.14 M NaCl, 1.0 mM orthovanadate, 2.5 mM MgCl2, and protease inhibitors. Samples were then immediately added to uPA-coated plates as described below. Cells in 35-mm wells were metabolically labeled with [35S]methionine. They were rinsed with serum-free, methionine/cys- teine-deficient DMEM. One milliliter of the same media containing 0.1 mCi/ml [35S]methionine was then added. After 2 hr, an additional milliter of complete DMEM containing 10% serum was added. Eighteen hours later, cells were exposed to asbestos as described above. Samples were collected and prepared as described for those labeled with [32P] orthophosphate. Solid-phase Affinity Plates for uPAR. The methods described by Busso et al. (28) for uPAR signaling in human epithelial cells and by Bohuslav et al. (22) for uPAR signaling in monocytes were used with slight modification. Microtiter wells were coated for 2 hr with 50 pl of 50 pg/ml of recombinant pro-uPAR (a gift from J. Henkin, Abbott Laboratories, Abbott Park, IL) in phosphate-buffered saline (PBS). The wells were rinsed three times with 100 pl of PBS containing 1% bovine serum albumin (BSA) and then incubated with 200 p1 of the same buffer for an additional 2 hr. The wells were then rinsed with cell lysis buffer and 100 pl of cell lysate was added to each well. To control for non-spe- cific absorption, aliquots of lysates were also added to wells coated with PBS plus 1% BSA, but no pro-uPAR. The lysates were incubated overnight at 40C with gende agi- tation. They were then rinsed 3 times with 200 pl of lysis buffer and then twice with kinase buffer. The samples were then either used for in vitro kinase assays or collected for electrophoresis by addition of 50 pil of electrophoresis buffer, transfer to a fresh storage tube, and then boiling for 5 min. Immunoprecipitations. Immuno- precipitations were performed as previously described (35). Briefly, following asbestos exposure, cells were lysed in cold RIPA buffer (35) and centrifuged to remove debris. Supernates were incubated overnight at 40C with specific antibody and protein A Sepharose beads (Pharmacia, Piscataway, NJ) coated with rabbit antimouse IgG (200 pg of antibody/ml of beads). The complexes were rinsed 3 times with RIPA buffer and twice with kinase buffer. Kinase assays were performed immediately to preserve activity. Kinase Assays. Tyrosine kinase activity of proteins purified with microtiter affin- ity plates or by immunoprecipitation were performed essentially as described (35 ). Kinase buffer (45 pl; 20 mM Hepes, pH 7.5; 5 mM MnCl2, 5 mM MgCl2, and 0.1 mM orthovanadate) was added to pel- lets of immunobeads or to microtiter wells. The kinase reactions were initiated by adding 5 pl of 32PyATP (5 pCi, 10 pM) and were incubated at 220C for 20 min. Incubations with immunobeads were stopped by placing on ice, centrifuging at 13,000 xgand 4?C for 30 sec, and replac- ing the kinase buffer with 50 pl of elec- trophoresis buffer. All samples were boiled for 5 min and separated by polyacry- lamide gel electrophoresis (PAGE). Gels were stained with Coomassie Blue to assure equal protein recoveries and autoradio- graphs were prepared for comparison of incorporated 32P04. These reaction condi- tions favor autophosphorylation and sub- strate phosphorylations by tyrosine kinases. Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 1 132 ENDOTHELIAL CELL SIGNALS IN RESPONSE TO ASBESTOS (-H (+) A Control C Mannosamine E Herbimycin A G . ii xI A rg - _ _s .p .rP ..ro .. . _ ` . _. _ . . _ _ _ ._ lmm. . w .. G Gly-Arg-Gly-Asp-Ser-Pro Figure 1. Morphological change in response to asbestos. Postconfluent endothelial cells were incubated v medium alone or media containing inhibitors for varying periods of time before addition of 5 pg/cm2 of chrysc asbestos to half of the cultures for 3 hr. The cultures were then photographed without fixing. Mannosamine mM) was added for 6 hr before asbestos exposure. Herbimycin A (1 pM) was added for 18 hr before asbeq exposure. GRGDSP peptide (100 pg/ml) was added for 1 hr before asbestos exposure. An F is placed below sc of the large fibers or fiber bundles in the field. The cells in the photographs are representative of those in at IE five microscopic fields. Results and Discussion ; Inhibition of GPI-Assembly or Tyrosine Kinase Activity Prevents Asbestos-induced Changes in Morphology K Nonlethal levels of asbestos, but not RCF- i1 fibers, cause marked changes in the morphology and phenotype of endothelial cells (14). As shown in Figure 1B, the m normal endothelial cell monolayer is dis- rupted by a 3-hr exposure to chrysotile asbestos as the cells move over and around B the fibers. The elongation of the cells can 1 be oberved as early as 2 hr after addition of chrysotile and is sustained beyond 72 hr (the longest time point examined). No overt toxicity is observed during these prolonged exposures (14). Re-alignment of the cells along the fibers implies that matrix contacts have been altered. Asbestos engages integrins on ; mesothelial cells (31) and changes in inte- grin signaling could mediate the motility of tmz the endothelial cells in Figure 1. However, D addition of a saturating amount of syn- thetic RGD-containing peptide (100 gg/ml), which is known to block integrin binding (30,31), did not prevent asbestos- s induced endothelial cell elongation (Figure i6- 1G,H). uPA and uPAR are also central to t cell adhesion and motility in various cell i types (18,20,24), including endothelial cells (17). In addition to binding uPA and facilitating its activation, uPAR regulates j fI-integrin function (29) and serves as a r high-affinity binding site for vitronectin (24). Therefore, the role of uPAR in F asbestos-induced changes in endothelial cell shape was examined in control and mannosamine-treated cells. Mannosamine prevents assembly of the GPI anchor and g thereby insertion of uPAR and other GPI- anchored proteins into the plasma mem- brane (24,36). The data in Figure 1C,D indicate that a 6-hr mannosamine treat- ment causes a slight increase in vacuoles, but has little effect on endothelial cell > shape. However, endothelial cells treated with mannosamine prior to addition of asbestos were resistant to asbestos-induced H shape change. The fact that chrysotile fibers are still attached to these cells indi- cates that GPI-anchored proteins mediate vith morphological change in response to )tile asbestos, but additional proteins or lipids ! (10 facilitate fiber binding. This is similar to stos previous results demonstrating that vit- ome ronectin is required for integrin-dependent east internalization of crocidolite, but not for adherence of crocidolite to cells (31). Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 1 133 BARCHOWSKY ET AL. Both integrins and GPI-anchored proteins signal through the Src-family of tyrosine kinases (22,37,38). Therefore, herbimycin A, a relatively selective inhibitor of Src-related kinases (39), was used to determine whether these kinases are required for morphologic change in response to chrysotile fibers. Eighteen- to twenty-four-hour treatment with her- bimycin A causes some loosening of con- tacts between endothelial cells (Figure 1 E,F). However, herbimycin A-treated cells did not elongate in response to asbestos. Again, the chrysotile fibers still attached to these cells. This suggests that the mecha- nisms for fiber binding are proximal to or independent from signals involved in morphologic change. Asbestos Activates uPAR Signaling Complexes uPAR associates with signaling complexes in specialized regions of the cell membrane (22,28). Therefore, cells were metaboli- cally labeled with [35S]methionine to examine whether chrysotile asbestos affects the composition of proteins complexed with uPAR. After exposing the cells to chrysotile fibers, lysates were prepared and aliquots were affinity purified in microtiter wells coated with pro-uPA. Nonadherent proteins were rinsed away; adherent pro- teins were lysed from the wells and then separated by PAGE. Data presented in Figure 2A demonstrate that asbestos causes proteins to complex with uPAR. The mass of several proteins in the complex, espe- cially those with apparent molecular weights of 116, 60, 42.7, and 38 kDa, increase relative to the mass of a 66-kDa protein. Synthesis of new proteins would be limited at these early time points, which suggests that asbestos mobilizes proteins in the cells. Protein interactions or mobilization is facilitated by changes in their phos- phorylation state. Cells were labeled with [32p] orthophosphate to examine the effect of asbestos on the phosphorylation state of proteins complexed with uPAR. Figure 2 shows that chrysotile increases the phospho- rylation of many proteins in the complex, most notably a 36-kDa protein and proteins with molecular weights greater than 97 kDa. The effect is transient but illustrates that there are many proteins of low abun- dance that become hyperphosphorylated. Also, asbestos changes the stoichiometry of the phosphoproteins in the complex. The most pronounced examples of this are the 38- and 60-kDa proteins. The increase in MW kDa ' 212 158 116 97.2 64.4 55.6 *.. 42.7 " 36.5 26.6 35s A kDa 212- 116- 66- 55.6 - 42.7 - t5 60 Time, min pro-uPA BSA 0 15 30 45 60 0 15 B Figure 2. Changes in uPAR-associated signaling complexes after exposure to asbestos. (A) The cells were labeled with either [35S]methionine or [32P]orthophosphate for 18 hr as described in "Materials and Methods." Chrysotile asbestos (5 pg/cm2) was added for the times given and then cells were lysed. Lysates were incubated in pro-uPA coated affinity plates and adherent proteins were separated by 8% PAGE. The gel was stained with Coomassie Brillant Blue and then autoradiographed. The data are a composite of the Coomassie Brillant Blue image of the molecular weight markers combined with an image of the autoradiograph. (B) Nonlabeled cells were exposed to 5 pg/cm2 of chrysotile for up to 60 min and then lysates were prepared and purified in microtiter wells coated with pro-uPA or BSA. Kinase assays were then performed and the resulting phosphoproteins were separated by PAGE. These data represent three separate experiments. the phosphorylation state of these proteins precedes significant increases in their mass in the complex (35S bands compared to 32p bands in Figure 2A). The increased phos- phorylation may serve as a recognition sig- nal for the proteins. However, other signals must be required for dissolution of the com- plexes, since the increased mass of the pro- teins in the complex is sustained longer than the increases in phosphorylation. Asbestos Increases Kinase Activities in uPAR Complex The data in Figure 2A indicate that the content of phosphoproteins in uPAR com- plexes is increased by asbestos. Therefore, in vitro kinase assays in the microtitre wells were used to study whether asbestos acti- vates kinases complexed with membrane- bound uPAR. Lysates were prepared from intact cells exposed to asbestos for up to 60 min. The lysates were incubated in micro- titer wells coated with pro-uPA or with the BSA- blocking solution alone. The wells were rinsed and kinase reactions were con- ducted in situ. The autoradiograph of the resulting phosphoproteins is shown in Figure 2B and illustrates that asbestos causes time-dependent increases in the phosphorylation of several bands. The den- sity of bands at 212, 98, and 60 kDa reached maximal intensity by 30 min. The strong intensity of a 48-kDa band did not peak until 45 min, indicating that asbestos differentially activates multiple kinases or kinase cascades in the intact cells. The specificity of the assay is demonstrated by the lack of kinase activity in the BSA wells. The differences between the phosphoryla- tion profiles in Figure 2A,B illustrates the limitations of the two analyses. uPAR and integrin signaling are highly dependent on the context of the intact cell and its matrix attachments. The in vitro kinase assays demonstrate that substrate phosphoryla- tion by kinases is activated by asbestos, but do not provide much information regard- ing the substrates that become phosphory- lated in the intact cell. Also, phosphatase activity is inhibited in the in vitro assay, which allows more phosphorylated sub- strates to accumulate. However, the data in Figures 1 and 2 demonstrate that adding asbestos to intact endothelial cells initiates uPAR-associated signaling cascades that precede cell elongation. Asbestos Inreases Tyrosine Kinase Actvities Associated with Src and FAK The data in Figure 1E,F indicate that Src- related kinases mediate asbestos-induced shape changes. Further, Src associates with FAK complexed with integrins (38). Therefore, in vitro kinase assays using endothelial cell immunoprecipitates were used to determine whether asbestos activates Src or FAK. RIPA lysates were prepared from control cells or cells exposed to equally nontoxic concentrations of chryso- tile or crocidolite asbestos for 15 min. The samples were split into two aliquots and Environmental Health Perspectives a Vol 105, Supplement 5 * September 1997 1 134 ENDOTHELIAL CELL SIGNALS IN RESPONSE TO ASBESTOS immunoprecipitated with monodonal anti- body recognizing either to Src (clone 327, Oncogene Science, Uniondale, NY) or to FAK (done 2A7, obtained from T. Parsons, University of Virginia, Charlottesville, VA). The immunobead/antigen complexes were assayed for kinase activity and the autoradi- ographs of the resulting phosphoproteins are shown in Figure 3A. Both types of asbestos induced formation of a doublet of 57- to 60-kDa phosphoproteins in the Src immunoprecipitates and of a similar band immunoprecipitating with FAK. There is no increased phosphorylation of a 120-kDa protein, which is the expected molecular weight of FAK. This indicates that auto- phosphorylation of FAK is not increased by asbestos. However, asbestos does appear to either increase substrate phosphorylation by FAK or to increase the activity of a kinase co-precipitating with FAK. Autophos- phorylation of an Src-related kinase brought into association with FAK in response to asbestos would explain the appearance of the 57- to 60-kDa band. However, further experiments will be required to identify this phosphoprotein. Asbests Alters the Profile of Proteins Co-preipitaing with FAK FAK is found in large intracellular signaling complexes at sites of integrin con- tacts with the extracellular matrix (38). Therefore, cells were metabolically labeled with [35S]methionine and then exposed to chrysotile to determine whether asbestos alters the composition of these complexes. The autoradiograph in Figure 3B presents the profile of [35S]-labeled proteins immuno- precipitated from control and asbestos- exposed cells with monoclonal antibody to FAK. Exposure to chrysotile results in a profound change in the protein profile by 15 min. There is loss of proteins in many regions of the autoradiograph. However, there is a significant gain in a 60-kDa band. This suggests that asbestos induces a dissolution of focal contacts and changes the proteins associated with FAK. Increased phosphorylation of focal adhesion proteins disrupts cytoskeletal elements and facilitates cell elongation (40,41). Therefore, cells labeled with [32P] ortho-phosphate were exposed to chrysotile to determine whether asbestos increases phosphorylation of FAK-associated proteins in the intact cell. Immunopre- cipitates of control and chrysotile-exposed cells demonstrate increased phosphorylation of many proteins after 30 min of exposure to the fibers, including a pronounced band at 60 kDa (Figure 3C). The increases in the 60-kDa band relative to the 116- and 50- kDa bands indicate that asbestos increases their phosphorylation state but not the distribution of ATP pools or cellular phosphate incorporation. Endothelial cells from different organs and species are heterogeneous in their responses. Therefore, chrysotile-induced kDa 205- 121 - 86 - 51- 8 46 4 O S X 0 - ' s 0 .L 0 0 . L) L) C. ca u C.) mAb 327 mAb 2A7 Chrysotile MW kDa 212 158 116 97.2 66.4 55.6 42.7 A - + + + phosphorylations were examined in [32P] orthophosphate-labeled human pul- monary microvascular endothelial cells. The experimental paradigm was identical to the studies in Figure 3C, except that the lysates were split into two aliquots. The first aliquot was immunoprecipitated with mAb 2A7 and the second with a monoclonal antibody to phosphotyrosine (clone pY69, Santa Cruz MW 35S-Labeled protein kDa 212 158 116 97.2 64.4 55.6 42.7 36.5 0 5 15 30 45 60 Time, min B mAb 2A7 pY69 212 116 66- 42.7 -.vv->;;.. ..... - - .. . . .: . -.. ... . : .. _ S: .. S: . .:s-:: M s :r. C: 5 15 30 5 15 30 5 15 30 0 15 30 lime, min Time, min C D Figure 3. Tyrosine phosphorylation and changes in signaling proteins complexed with FAK. (A) Lysate were pre- pared from control cells or cells exposed to either 10 pg/cm2 of chrysotile or 5 pg/cm2 of crocidolite asbestos for 15 min. The lysates were immunoprecipitated with monoclonal antibodies recognizing either Src (mAb 327) or FAK (mAb 2A7). Kinase assays were performed using these precipitates and the resulting phosphoproteins were sepa- rated by PAGE and detected by autoradiography. (B) [35S]Methionine-labeled cells were exposed to chrysotile (5 pg/cm2), lysed in the lysis buffer for uPAR extraction, and then separated by PAGE. The composite image is of the Coomassie Brillant Blue-stained molecular weight markers and the autoradiograph of the dried gel. (C) Porcine aor- tic cells were labeled for 1 hr with [32P]orthophosphate before adding buffer or chrysotile (5 pg/cm2). Lysates were prepared in RIPA buffer and immunoprecipitated with mAb 2A7. The proteins were separated by PAGE, stained with Coomassie Brillant Blue, and then detected by autoradiography of dried gels. 3D: Human microvascular endothelial cells were labeled with [32Pjorthophosphate as in Figure 3C and exposed to chrysotile (5 pg/cm2). RIPA lysates were prepared and immunoprecipitated with either mAb 327 or pY69, which recognize phosphotyrosine. The precipitated proteins were separated by PAGE and detected by autoradiography. All experiments were performed in triplicate. Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 1 135 BARCHOWSKY ET AL Biotechnology, Santa Cruz, CA). The pro- teins in the immunoprecipitates were sepa- rated on 8% polyacrylamide gels and phosphoproteins are shown in the autoradi- ography in Figure 3D. As observed in the porcine aortic cells, treatment of the human microvascular cells with 5 pg/cm2 of chrysotile asbestos resulted in time-depen- dent increases in phosphorylation of 60- and 212-kDa proteins co-precipitating with FAK (Figure 3D) relative to a 116-kDa band. Increases were also observed in the pY69 immunoprecipitates, which suggests that the proteins become hyperphosphorylated on tyrosine residues. Conclusion These data support the hypothesis that sub- lethal amounts of asbestos initiate motility changes through activation of uPAR- and integrin-associated signaling cascades. Elongation of the cells in response to chrysotile asbestos is greatly reduced by preventing insertion of uPAR into the plasma membrane or by inhibiting tyrosine kinase signaling cascades. Asbestos increases the association of proteins with uPAR signaling complexes. However, at the same time, asbestos causes dissolution of pro- teins associated with FAK. Asbestos acti- vates p6O Src and perhaps other Src-related kinases, which may mediate the changes in uPAR and FAK protein complexes. More investigations will be required for the iden- tification of the proteins that are altered in response to asbestos and the relationships of these alterations to facilitating endothe- lial cell activation and motility in response to asbestos. REFERENCES 1. Mossman BT, Gee JBL. Asbestos-related diseases. N Engl J Med 320:1721-1730 (1989). 2. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 12:293-315 (1992). 3. Rom WN, Travis WD, Brody AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 143:408-422 (1991). 4. Gross TJ, Cobb SM, Gruenert DC, Peterson MW. Asbestos exposure increases human bronchial epithelial cell fibrinolytic activity. Am J Physiol 264:L276-L283 (1993). 5. Mossman, BT, Gee JBL. Pulmonary reactions and mechanisms of toxicity of inhaled fibers. In: Toxicology of the Lung (Gardner DE, Crapo JD, McClellan RO, eds). New York:Raven Press, 1993;371-387. 6. Branchaud RM, MacDonald JL, Kane AB. Induction of angio- genesis by intraperitoneal injection of asbestos fibers. FASEB J 3:1747-1752 (1989). 7. Hauser IA, Setter E, Bell L, Madri JA. Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitro. Am J Pathol 143:173-180 (1993). 8. Mignatti P, Rifkin DB. Biology and biochemistry of pro- teinases in tumor invasion. Physiol Rev 73:161-195 (1993). 9. Shetty S, Kumar A, Johnson A, Pueblitz S, Idell S. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol 268:L972-L982 (1995). 10. McGavran PD, Moore LB, Brody AR. Inhalation of chrysotile asbestos induces rapid cellular proliferation in small pulmonary vessels of mice and rats. Am J Pathol 136:695-705 (1990). 11. Callahan KS, Griffith DE, Garcia JG. Asbestos exposure results in increased lung procoagulant activity in vivo and in vitro. Chest 98:112-119 (1990). 12. Garcia JG, Dodson RF, Callahan KS. Effect of environmental particulates on cultured human and bovine endothelium. Cellular injury via an oxidant-dependent pathway. Lab Invest 61:53-61 (1989). 13. Garcia JGN, Gray LD, Dodson RF, Callahan KS. Asbestos- induced endothelial cell activation and injury. Am Rev Resp Dis 138:958-964 (1989). 14. Treadwell MD, Mossman BT, Barchowsky A. Induction of neutrophil adherence to endothelial cells following exposure to asbestos. Toxicol Appl Pharmacol 139:62-70 (1996). 15. Stetler-Stevenson WG, Liotta LA, Kleiner DEJ. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1441 (1993). 16. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD. Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90:5021-5025 (1993). 17. Lu H, Mabilat C, Yeh P, Guitton JD, Li H, Pouchelet M, Shoevaert D, Legrand Y, Soria J, Soria C. Blockage of uroki- nase receptor reduces in vitro the motility and the deformability of endothelial cells. FEBS Lett 380:21-24 (1996). 18. Rao NK, Shi GP, Chapman HA. Urokinase receptor is a multi- functional protein: influence of receptor occupancy on macrophage gene expression. J Clin Invest 96:465-474 (1995). 19. Gyetko MR, Sitrin RG, Fuller JA, Todd RF, Petty H, Standiford TJ. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol 58:533-538 (1995). 20. Sitrin RG, Todd RFIII, Petty HR, Brock TG, Shollenberger SB, Albrecht E, Gyetko MR. The urokinase receptor (CD87) facilitates CD 11 /CD 1 8-mediated adhesion of human mono- cytes. J Clin Invest 97:1942-1951 (1996). 21. Stahl A, Mueller BM. The urokinase-type plasminogen activa- tor receptor, a GPI-linked protein, is localized to caveolae. J Cell Biol 129:335-344 (1995). 22. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidel UH, Majdic 0, Bartke I, Knapp W, Stockinger H. Urokinase plas- minogen activator receptor, P2-integrins, and SRc-kinases within a single receptor complex of human monocytes. J Exp Med 181:1381-1390 (1995). 23. Waltz DA, Chapman HA. Reversible cellular adhesion to vit- ronectin linked to urokinase receptor occupancy. J Biol Chem 269:14746-14750 (1994). 24. Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380-32388 (1994). 25. Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016-1019 (1991). 26. Englund PT. The structure and biosynthesis of glycosyl phos- phatidylinositol protein anchors. Annu Rev Biochem 62:121-138 (1993). 27. Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. Cysteine3 of Src family protein tyrosine kinase deter- mines palmitoylation and localization in caveolae. J Cell Biol 126:353-363 (1994). 28. Busso N, Masur SK, Lazega D, Waxman S, Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol 126:259-270 (1994). 29. Wei Y, Lukashev L, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA. Regulation of integrin function by the urokinase receptor. Science 273:1551-1555 (1996). 30. Donaldson K, Miller BG, Sara E, Slight J, Brown RC. Asbestos fibre length-dependent detachment injury to alveolar epithelial cells in vitro: role of a fibronectin-binding receptor. Int J Exp Pathol 74:243-250 (1993). 1136 Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 ENDOTHELIAL CELL SIGNALS IN RESPONSE TO ASBESTOS 31. Boylan AM, Sanan DA, Sheppard D, Broaddus VC. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin avP5. J Clin Invest 96:1987-2001 (1995). 32. Barchowsky A, Tabrizi K, Kent RS, Whorton AR. Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells. J Clin Invest 83:1153-1159 (1989). 33. Knedler A, Ham RG. Optimized medium for clonal growth of human microvascular endothelial cells with minimum serum. In Vitro Cell Dev Biol 32767-32513 (1987). 34. Barchowsky A, Williams ME, Benz CC, Chepenick KP. Oxidant-sensitive protein phosphorylation in endothelial cells. Free Radic Biol Med 16:771-779 (1994). 35. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M. Oxidant-sensitive and phosphorylation-depen- dent activation of NF-kappaB and AP-1 in endothelial cells. Am J Physiol Lung Cell Mol Physiol 269:L829-L836 (1995). 36. Sevlever D, Rosenberry TL. Mannosamine inhibits the synthesis of putative glycoinositol phospholipid anchor precursors in mammalian cells without incorporating into an accumulated intermediate. J Biol Chem 268:10938-10945 (1993). 37. Shenoy-Scaria AM, Gauen LK, Kwong J, Shaw AS, Lublin DM. Palmitylation of an amino-terminal cysteine motif of pro- tein tyrosine kinases p56Lck and p59Fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol Cell Biol 13:6385-6392 (1993). 38. Clark EA, Brugge JS. Integrins and signal transduction: the road taken. Science 268:233-239 (1995). 39. Uehara Y, Fukazawa H. Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol 201:370-379 (1991). 40. DeClue JE, Martin GS. Phosphorylation of talin in rous sacroma virus-transformed cells. Mol Cell Biol 7:371-378 (1987). 41. Turner CE, Pavalko FM, Burridge K. The role of hosphoryla- tion and limited proteolytic cleavage of talin and vinculin in the disruption of focal adhesion integrity. J Biol Chem 264:11938-11944 (1989). Environmental Health Perspectives * Vol 105, Supplement 5 * September 1997 1137